semaglutide 503b pharmacy US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs Empower - For a limited
Description
Ingredient System Designed for Market Credibility
Patients using these medications report noticing an increase in fine lines, wrinkles, loose and sagging skin, and a hollowed-out facial appearance
Semaglutide does not commonly cause heart palpitations, but it might contribute to them in certain situations
This is a standard rule across compounded prescription medications, not a policy specific to altRx
